chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Died after getting the vaccine.; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for a patient (Doctor). A patient of unspecified age and gender received bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. No medical history and no concomitant medications were not reported. The reporter was asking about a doctor in (Withheld) that died after getting the vaccine. She wanted to know what the reports are. She said that this happened in the beginning around Dec2020. She wanted to know what the cause of death was. she insisted on getting information or a supervisor or anyone that could give her answers. The patient died on Dec2020. It was not reported if an autopsy was performed.  The following information was provided to the reporter from CDC website: The Centers for Disease Control and Prevention (CDC) conducted descriptive analyses of safety data from the first month of vaccination with COVID-19 vaccines in the United States (14Dec2020-13Jan2021). During this period, 13,794,904 vaccine doses of Pfizer-BioNTech and Moderna COVID-19 vaccines were administered and a total of 113 deaths were reported to the CDC's Vaccine Adverse Event Reporting System (VAERS). Initial doses were recommended for healthcare personnel and long-term care facility (LTCF) residents. This analysis, which evaluated available information from death certificates, autopsy reports, medical records, and clinical descriptions from VAERS reports and health care providers, concluded that a causal relationship between COVID-19 vaccination and death was not suggested  No follow-up attempts are possible; Information on batch/lot number cannot be obtained. No further information expected.; Reported Cause(s) of Death: Died after getting the vaccine.
Information has been received from a physician concerning a 14 year old male who on an unspecified date was vaccinated with PROQUAD (Merck upgrade process) instead of his second scheduled dose of VARIVAX (Merck) (MSD). No medical attention was sought. Follow up information was received from the physician who reported that the nurses grabbed the wrong product off the shelf. She further stated that the nurses forgot the PROQUAD (Merck upgrade process) only went up to 12 years of age. They did not realize that the patient was over 12 years old and should have received MMR II (MSD) and VARIVAX (Merck) (MSD) separately. Additional information is not expected.
redness, inflammation and pain at injection site extending 4" from site and half-way around arm. Pt told to apply cold compresses x1 day then warm compresses the next
Waited in clinic 15 minutes, after returning to car felt parathesia on Left side of face. In clinic also c/o some on Right. Stayed another 15 minutes without progression of symptoms. Per pharmacist patient notified healthcare provider and is to use wet compresses and ibuprofen prn. If symptoms escalate instructed to call 911.  Only previous issue was swelling from high dose prednisone. Very anxious over shot. Signed in then left clinic to mull over type of vaccine and desire for vaccination. Returned to get J&J.
Patient had lost a lot of weight over a year ago and reported that patient had lost 145 lbs.; Second Moderna primary dose each time after the injection patient experienced a red left arm; Second Moderna primary dose each time after the injection patient experienced a swollen left arm; Second Moderna primary dose each time after the injection she experienced a sore left arm; This spontaneous case was reported by a patient and describes the occurrence of WEIGHT DECREASED (Patient had lost a lot of weight over a year ago and reported that patient had lost 145 lbs.), VACCINATION SITE ERYTHEMA (Second Moderna primary dose each time after the injection patient experienced a red left arm), VACCINATION SITE SWELLING (Second Moderna primary dose each time after the injection patient experienced a swollen left arm) and VACCINATION SITE PAIN (Second Moderna primary dose each time after the injection she experienced a sore left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (Date was reported as 25 years ago Patient reported that patient  HCP changed the blood pressure medication a year ago.) and Thyroid disorder (Date was reported as 15 to 20 years ago.  There was no change in status such as improvement or worsening.).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient experienced WEIGHT DECREASED (Patient had lost a lot of weight over a year ago and reported that patient had lost 145 lbs.), VACCINATION SITE ERYTHEMA (Second Moderna primary dose each time after the injection patient experienced a red left arm), VACCINATION SITE SWELLING (Second Moderna primary dose each time after the injection patient experienced a swollen left arm) and VACCINATION SITE PAIN (Second Moderna primary dose each time after the injection she experienced a sore left arm). At the time of the report, WEIGHT DECREASED (Patient had lost a lot of weight over a year ago and reported that patient had lost 145 lbs.) outcome was unknown and VACCINATION SITE ERYTHEMA (Second Moderna primary dose each time after the injection patient experienced a red left arm), VACCINATION SITE SWELLING (Second Moderna primary dose each time after the injection patient experienced a swollen left arm) and VACCINATION SITE PAIN (Second Moderna primary dose each time after the injection she experienced a sore left arm) had resolved.            On 24-Aug-2021, the patient received the Flu Vaccine (Intramuscular) in right deltoid.  No concomitant medication information was provided. No treatment medication were provided.   This case was linked to MOD-2022-577887, MOD-2022-577896, MOD-2022-577806 (Patient Link).
Nausea vomiting diarrhea severe headache unable to eat so far for 3 Days cannot lift my head fever chills. Severe internal ear pain and headache but it's not touched by Tylenol or Ibuprofen
Numbness on left side of face 1-2 hours after injection in left arm.  Feels like NOVACAINE when it is almost worn off.  Has improved in past week, but still not fully recovered around upper left lip area.  Sharp, shooting pain in and of right foot 2-3 times in past week.  Feels nerve - related.  Other symptoms more typical: fever, achy have now gone.  No treatment.
Narrative: COVID infection following COVID vaccine series 04/02, Pfizer, dose #1 04/23, Pfizer, dose #2 12/27 COVID swab, result: detected 1/3 COVID swab, result: detected 12/19 pt cc: chills, cough, diarrhea, fatigue fever, headache,  loss of taste or smell dyspnea exposure: unknown
pt recv vax 9AM  & T103.5 reported by 6PM-bathed & given APAP temp dec;pt later in evening noted to have staring episodes, @ 15mo old began to stumble-not noted before;17MAR98 MD visit r/o convulsive disorder;19MAR98 EEG abn petit mal sz
Had a mild sunburn from the day before on left and right hands as well as face. Face and left hand healed normally, right hand became bright red, painful to touch, burning sensation, swollen, cuts and cracks in skin.
Information has been received from a registered nurse concerning a 68 year old male with no relevant medical history reported or illness at the time of vaccination who on 21-MAY-2007 was vaccinated intramuscularly in the right deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (lot 655588/0883F). On 21-MAY-2007, the patient experienced pain and swelling at the injection site and erythema from shoulder to elbow for 1 week. Subsequently, the patient recovered. This is one of several reports from the same source. Additional information is not expected.
6 days after receiving her second covid-19 injection at a "church clinic", patient noticed a red, raised, itchy rash to the vaccine site.
Received Influenza vaccine 10/24/14 4:07 pm. Had arm muscle pain after vaccine. Saturday at 10 am had numbness from shoulder to fingers lasting till 10/27/14 at 8AM. No meds, no ice/heat. Numbness went away but still with pain in upper. Takes 400mg Ibuprofen daily for migraines. Applying heat.
feeling way, way tired; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site) and FATIGUE (feeling way, way tired) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 018A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 01-Apr-2021, the patient experienced FATIGUE (feeling way, way tired). On 27-Mar-2021, VACCINATION SITE PAIN (soreness at the injection site) had resolved. At the time of the report, FATIGUE (feeling way, way tired) outcome was unknown. Not Provided          He has been doing rigorous dieting and is not sure whether this is coming from that or the vaccine.  No concomitant product use was reported No treatment information was provided  Action taken with mRNA-1273 was not applicable
The patient was diagnosed with Myasthenia Gravis 1 month after receiving the second dose of the Moderna Covid-19 vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of MYASTHENIA GRAVIS (The patient was diagnosed with Myasthenia Gravis 1 month after receiving the second dose of the Moderna Covid-19 vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYASTHENIA GRAVIS (The patient was diagnosed with Myasthenia Gravis 1 month after receiving the second dose of the Moderna Covid-19 vaccine.) (seriousness criterion medically significant). At the time of the report, MYASTHENIA GRAVIS (The patient was diagnosed with Myasthenia Gravis 1 month after receiving the second dose of the Moderna Covid-19 vaccine.) outcome was unknown.            No concomitant medications were provided. Treatment for the event was not provided.  Company comment Very limited information regarding this event has been provided at this time. However, based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-008664 (Patient Link).; Sender's Comments: Very limited information regarding this event has been provided at this time. However, based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt recv vax on 11/21/98; on 11/23/98 pt exp vomiting, fever, swollen leg, hive rash on leg, tremors, crying
When she coughs, it has her chest sore; Aches/body ache; Diarrhea; Running nose; Arm is really red; Had an allergic reaction; coughs; Arm is really sore; Real bad headache; chills; Got really sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got really sick), CHEST PAIN (When she coughs, it has her chest sore), PAIN (Aches/body ache), DIARRHOEA (Diarrhea) and RHINORRHOEA (Running nose) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Aug-2021, the patient experienced ILLNESS (Got really sick). On an unknown date, the patient experienced CHEST PAIN (When she coughs, it has her chest sore), PAIN (Aches/body ache), DIARRHOEA (Diarrhea), RHINORRHOEA (Running nose), ERYTHEMA (Arm is really red), ALLERGY TO VACCINE (Had an allergic reaction), COUGH (coughs), MYALGIA (Arm is really sore), HEADACHE (Real bad headache) and CHILLS (chills). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN EXTRA STRENGTH) at a dose of 1 dosage form; FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for Allergy, at a dose of 1 dosage form; HYDROCORTISONE at an unspecified dose and frequency and CODEINE PHOSPHATE, GUAIFENESIN (GUAIATUSSIN AC) at a dose of 1 dosage form. At the time of the report, ILLNESS (Got really sick), CHEST PAIN (When she coughs, it has her chest sore), PAIN (Aches/body ache), DIARRHOEA (Diarrhea), RHINORRHOEA (Running nose), ERYTHEMA (Arm is really red), ALLERGY TO VACCINE (Had an allergic reaction), COUGH (coughs), MYALGIA (Arm is really sore), HEADACHE (Real bad headache) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) COVID-19 Virus test was negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She went to the ER on 28AUG2021 around 8pm and was discharged at 2:30am.  No Concomitant medications was provided.  she uses inhalers for her Bronchitis.
menstruation came sooner/menstruation came later; people who menstruated after 5 years of not doing so; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Jun-2021 and was forwarded to Moderna on 03-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of MENSTRUATION IRREGULAR (menstruation came sooner/menstruation came later) and MENSTRUATION DELAYED (people who menstruated after 5 years of not doing so) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not provided) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION IRREGULAR (menstruation came sooner/menstruation came later) and MENSTRUATION DELAYED (people who menstruated after 5 years of not doing so). At the time of the report, MENSTRUATION IRREGULAR (menstruation came sooner/menstruation came later) and MENSTRUATION DELAYED (people who menstruated after 5 years of not doing so) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Last evening, his right deltoid area had mild redness w/o pain or itching. This morning, his arm has  large area of redness that is pruritic and sometimes painful, covering most of his right upper arm. Nurse gave him an ice pack, which offered some relief.  No associated systemic symptoms, other than coughing that preceded this injection.  Given flu vaccine with preservative yesterday. Of note ~ Last year, he developed mild redness with firm palpable mass after receiving  his flu vaccine. That reaction did not spread or change in size. Child received preservative free vaccine last year.
pt febrile for 2 days, pt syncopized on toilet day 2 post vaccination, pt presents to ED, pt then had a seizure and became grossly diaphoretic
Patient was to receive  Pfizer Covid19 vaccination on the appointment but a single shot of Jassen Covid19 was given to her by mistake. Patient had no adverse reactions by the time she left the pharmacy with her family. Her father was taking her to see her PCP and no further adverse reactions had been reported to the pharmacy when father called us at around 2:00pm.  Further adverse reactions would be reported once the patient's family contact pharmacy again
Presented with chest pain.  ECHO 12/15 with no effusion, but on presentation to ED, 12/17,  CT and ECHO with 1 cm circumferential effusion with no tamponade.
This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (This vial had spent more than 30 days in the refrigerator, and the 30-day BUD was 14-Aug-2022), PRODUCT STORAGE ERROR (This vial had spent more than 30 days in the refrigerator) and NO ADVERSE EVENT (No adverse event) in a 3-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AR9237B and AR9237B) for COVID-19 vaccination. Patient did not have allergies to medications, food and other products. Unknown whether the patient ever been diagnosed with/ tested positive for COVID-19. No acute illnesses at the time of vaccination and up to one month before. No chronic or long-standing health condition. On 11-Jul-2022 at 11:46 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 25 microgram. On 15-Aug-2022 at 9:33 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 25 microgram. On 15-Aug-2022 at 9:33 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (This vial had spent more than 30 days in the refrigerator, and the 30-day BUD was 14-Aug-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (This vial had spent more than 30 days in the refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (This vial had spent more than 30 days in the refrigerator, and the 30-day BUD was 14-Aug-2022), PRODUCT STORAGE ERROR (This vial had spent more than 30 days in the refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (This vial had spent more than 30 days in the refrigerator, and the 30-day BUD was 14-Aug-2022) and PRODUCT STORAGE ERROR (This vial had spent more than 30 days in the refrigerator). Patient was not taking any prescriptions, over-the-counter medications, dietary supplements, or herbal remedies at time of vaccination and/or at the time of the adverse event. Patient race was reported as "private". Vial was initially stored in the refrigerator on 14-Jul-2022 and vial did not undergo any temperature excursions. That vial had spent more than 30 days in the refrigerator and the 30-day BUD was 14-Aug-2022. No reported symptoms. No additional doses, medications, or treatments had been administered at that time. This case was linked to US-MODERNATX, INC.-MOD-2022-629582 (E2B Linked Report). Sender's Comments: US-MODERNATX, INC.-MOD-2022-629582: Master case.
Potential AE due to doses administered from vials that may have been compromised; Administered vaccine from vials that may have been compromised; Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion). At the time of the report, IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine from vials that may have been compromised) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Reporter stated that, they had a group of 13 pharmacies and had administered the Moderna vaccine. Their digital data loggers and freezers expired before they were re-calibrated. They were aware in some of the freezers there was a temperature excursion that their data logs showed. The vaccines had never reached a temperature that was considered outside of frozen recommended range. The data loggers had laps where they were not considered calibrated, so they had a paper-logs to monitor those temperatures. This was in several different freezers and the vial temperatures never went out of range when they were using the paper log. The reporter was concerned that the vials have been compromised. Further reporter stated that, vaccines administered at their pharmacies that were stored in an unapproved freezer and thus, might have been compromised. The beyond use date for vial was reported as 01-Dec-2021 to 15-Dec-2021. MODERNA DATE ORDERED was reported as 01-Nov-2021 and 15-Nov-2021. No treatment information was reported.
Paresthesia - Both breasts TX Elavic 25 mg Q H 5x2
lost smell/taste, dizziness, nausea, sinus pain/pressure, body aches, extreme tiredeness, unable to focus, migraines, unable to eat/keep food down
Ever since I have gotten the vaccine I have had several events of fever, headache, chills, joint pain and overall weakness.  I have never had this happen before the vaccine.  Also the injection site is still sore like I have a charlie horse that won't go away.  I get the flu shot ever year and this has never happened before either.